See Full Document Text
GOVERNMENTOFINDIA
MINISTRYOFHEALTH AND FAMILYWELFARE
DEPARTMENTOFHEALTH AND FAMILYWELFARE
LOK SABHA
UNSTARREDQUESTION NO. 2237
TO BE ANSWERED ON31STJULY2026
AVAILABILITYOFESSENTIALMEDICINES IN GOVERNMENTHEALTHCARE
INSTITUTIONS
2237. SHRIMALAIYARASAND:
Will the Ministerof HEALTH AND FAMILYWELFAREbe pleasedtostate:
(a) the current status of availability of essential medicines and diagnostic facilities in Government
healthcare institutions in rural areas of Tamil Nadu, including Primary Health Centres (PHCs),
Ayushman Arogya Mandirs (AAMs) and district hospitals, district-wise including Kallakurichi
Parliamentary Constituency;
(b) the details of funds allocated, released and utilised under various Central health schemes for
procurement of essential medicines strengthening of laboratories and improving diagnostic
services inrural Tamil Nadu during the last five years;
(c) whether the Government has assessed shortages, stock-outs or gaps in the availability of essential
medicines, medical supplies and diagnostic facilities in rural healthcare centres of the said State
andif so, the details threreof; and
(d) the steps being taken by the Union Government to ensure uninterrupted availability of affordable
medicines, essential diagnostics and quality healthcare services for rural populations, particularly
inremote andunderserved areasof the said State?
ANSWER
THE MINISTEROFSTATE IN THE MINISTRYOFHEALTH AND FAMILY
WELFARE
(SHRIPRATAPRAO JADHAV)
(a) & (b): ‘Public Health’ and ‘Hospital’ are State subject and the responsibility for strengthening
of healthcare system including availability of essential medicines and diagnostic facilities in
Government healthcare institutions lieswith respective State/UTGovernments.
Under National Health Mission (NHM), financial and technical support is provided to
States/UTs tostrengthen theirhealthcaresystem based onproposals receivedfrom States/UTs intheir
ProgrammeImplementation Plan(PIP)within theirresource envelope.
Each year, PIP is formulated by every State/ UT based on district and State-level
planning processes, encompassing all activities and expenditures under NHM. State-wise fund
allocationcanbe accessed at:
https://nhm.gov.in/index1.php?lang=1&level=1&sublinkid=1377&lid=744As per the information provided by the State Government of Tamil Nadu, the drugs
were categorized in to Essential Drug List (EDL) and Speciality Drug List (SDL) wherein 408 EDL
and400SDLare availableinTamil Nadu Medical ServicesCorporation (TNMSC) warehouses.
Under CentrallySponsoredScheme (CSS)componentof PradhanMantri – Ayushman
Bharat Health Infrastructure Mission (PM-ABHIM) for the State of Tamil Nadu, Administrative
approvals have been accorded to the State for five years (i.e. FY2021-22 to 2025-26) for an amount
of Rs.74.44 Cr. for construction and strengthening of 38 Integrated Public Health Labs (IPHLs) to
strengthen diagnostic infrastructure byenhancingaccesstoqualityessential diagnostic services.
Under Fifteenth Finance Commission (FC-XV) for the State of Tamil Nadu, Rs.301.07
Cr. has been approved from FY 2021-22 to FY 2025-26 for strengthening of Block Public Health
Unit (BPHU) and Rs.301.07 Cr. has been released during the scheme period for establishment and
strengthening of 386BPHU, tostrengthen disease surveillance andprovide diagnostic support.
(c) and (d): As per the information provided by the State Government of Tamil Nadu, there is no
shortage/stock-outs of drugs identified so far. Also, action is being taken to include certain drugs in
the EDL. Under Integrated Essential Laboratory Services (IELS) periodic gap analysis of essential
diagnostic investigations is carried out to assess the availability of diagnostic services across
healthcare facilities as well as Stock availability and utilisation are continuously monitored through
Drug Distribution andManagement System (DDMS) Portal.
Further, Government of India supports the States in terms of drugs and diagnostics
services through State PIP proposals under Free Drugs Services Initiative and Free Diagnostic
ServicesInitiative everyyear.
*****